IP Library Granted Patent US 9,867,898
Granted Patent B2
US 9,867,898 · App. 15/090,072 · Granted Jan 16, 2018

Clay-based hemostatic agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,898
App. No.
15/090,072
Granted
Jan 16, 2018
Kind
B2
Abstract

A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.

Claims (34)

1. A hemostatic device for promoting the clotting of blood, the device comprising:

a substrate;

a clay material disposed on a surface of the substrate and distinct from the substrate;

a binder that is distinct from the substrate and the clay, that adheres at least a portion of the clay material to the surface of the substrate so that the surface is substantially free of loose clay;

wherein the binder comprises one or more of chitosan, guar gum, a gelatinized starch, a polysaccharide, a cellulose, and calcium alginate;

wherein the clay material is positioned on the surface of the device in a region configured to contact blood from a bleeding wound, thereby promoting clotting.

2. The device of claim 1 , wherein the binder comprises a gelatinized starch.

3. The device of claim 1 , wherein the binder comprises calcium alginate.

4. The device of claim 1 , wherein the binder comprises a polysaccharide.

5. The device of claim 1 , wherein the binder comprises a cellulose.

6. The device of claim 1 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

7. The device of claim 1 , wherein the clay comprises kaolin.

8. The device of claim 1 , wherein the substrate is flexible to allow the substrate to form to a shape of the bleeding wound and to retrain a shape of the bleeding wound.

9. The device of claim 1 , wherein the substrate is gauze.

10. The device of claim 1 , wherein at least one of an antibiotic, an antifungal agent, an anti-microbial agent, a silver ions, or copper ions is mixed with, associated with, or incorporated into the clay material.

11. The device of claim 1 , further comprising a release agent.

12. A hemostatic device for promoting the clotting of blood, the device comprising:

an absorbent substrate;

a clay material disposed on the surface of the substrate material and initially separate from the substrate material;

a binder comprising an alginate that is distinct from the substrate material and the clay, that adheres at least a portion of the clay material to the surface of the substrate material so that the surface is substantially free of loose clay;

wherein the clay material is positioned on the surface of the device in a region configured to contact blood from a bleeding wound, thereby promoting clotting.

13. The device of claim 12 , wherein the absorbent substrate is gauze.

14. The device of claim 12 , wherein the clay comprises kaolin.

15. The device of claim 12 , wherein the substrate is flexible to allow the substrate to form to a shape of the bleeding wound and to retrain a shape of the bleeding wound.

16. The device of claim 12 , wherein at least one of an antibiotic, an antifungal agent, an anti-microbial agent, a silver ions, or copper ions is mixed with, associated with, or incorporated into the clay material.

17. The device of claim 12 , further comprising a release agent.

18. The device of claim 17 , wherein the release agent is selected from the group consisting of polyvinyl alcohol, glycerol, carboxymethyl cellulose, silicone, and gelatinized starch.

19. A hemostatic device for promoting the clotting of blood, the device comprising:

an absorbent substrate;

a clay material disposed on the surface of the substrate material;

a binder comprising a cellulose that is distinct from the substrate material and the clay, that adheres at least a portion of the clay material to the surface of the substrate material so that the surface is substantially free of loose clay;

wherein the absorbent substrate initially exists separately from the clay material;

wherein the clay material is positioned on the surface of the device in a region configured to contact blood from a bleeding wound, thereby promoting clotting.

20. The device of claim 19 , wherein the clay material comprises kaolin.

Assignments (9)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
SECURITY INTEREST Recorded Mar 2, 2021
From: Z-MEDICA, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055455/0099 →